Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10946)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 10, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Johansen OE. Interpretation of cardiovascular outcome trials in type 2 diabetes needs a multiaxial approach. World J Diabetes 2015; 6(9): 1092-1096 [PMID: 26265995 DOI: 10.4239/wjd.v6.i9.1092] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v6/i9/1092.htm |
| Number | Citing Articles |
| 1 |
Laura K. Kjær, Vanja Cejvanovic, Trine Henriksen, Kasper M. Petersen, Torben Hansen, Oluf Pedersen, Cramer K. Christensen, Christian Torp-Pedersen, Thomas A. Gerds, Ivan Brandslund, Thomas Mandrup-Poulsen, Henrik E. Poulsen. Cardiovascular and All-Cause Mortality Risk Associated With Urinary Excretion of 8-oxoGuo, a Biomarker for RNA Oxidation, in Patients With Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care 2017; 40(12): 1771 doi: 10.2337/dc17-1150
|
| 2 |
Darren K. McGuire, Nikolaus Marx, Odd Erik Johansen, Silvio E. Inzucchi, Julio Rosenstock, Jyothis T. George. FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later. Diabetes, Obesity and Metabolism 2019; 21(5): 1073 doi: 10.1111/dom.13645
|
| 3 |
Christian Gerdes, Nicolle Müller, Gunter Wolf, Martin Busch. Nephroprotective Properties of Antidiabetic Drugs. Journal of Clinical Medicine 2023; 12(10): 3377 doi: 10.3390/jcm12103377
|
| 4 |
Jisu Shin, Xuan Zhou, Joanne T. M. Tan, Elina Hyppönen, Beben Benyamin, S. Hong Lee. Lifestyle Modifies the Diabetes-Related Metabolic Risk, Conditional on Individual Genetic Differences. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.759309
|
| 5 |
Francisco Carlos Carramiñana Barrera. Seguridad de los inhibidores de la dipeptidil peptidasa 4. Medicina de Familia. SEMERGEN 2018; 44: 10 doi: 10.1016/S1138-3593(18)30370-8
|
| 6 |
Ilkka Tikkanen, Robert Chilton, Odd Erik Johansen. Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension. Current Opinion in Nephrology and Hypertension 2016; 25(2): 81 doi: 10.1097/MNH.0000000000000199
|
| 7 |
Cristiana Vitale, Giuseppe M. C. Rosano, Krishna Prasad. Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes. Cardiovascular Diabetology 2016; 15(1) doi: 10.1186/s12933-016-0379-4
|
| 8 |
K.A. Berk, T.P. Oudshoorn, A.J.M. Verhoeven, M.T. Mulder, A.J.M. Roks, W.A. Dik, R. Timman, E.J.G. Sijbrands. Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes. Clinical Nutrition ESPEN 2016; 15: 101 doi: 10.1016/j.clnesp.2016.06.011
|
| 9 |
Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello. Current perspectives on cardiovascular outcome trials in diabetes. Cardiovascular Diabetology 2016; 15(1) doi: 10.1186/s12933-016-0456-8
|
| 10 |
Guntram Schernthaner, Roger Lehmann, Martin Prázný, Leszek Czupryniak, Kristine Ducena, Peter Fasching, Andrej Janež, Avraham Karasik, Peter Kempler, Emil Martinka, Marina V. Shestakova, Lea Smirčić Duvnjak, Tsvetalina Tankova. Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG). Cardiovascular Diabetology 2017; 16(1) doi: 10.1186/s12933-017-0622-7
|